510(k) K230651

BD BBL™ Sensi-Disc™ Lefamulin 20µg (LMU-20) by Becton, Dickinson and Company — Product Code JTN

K230651 is an FDA 510(k) premarket notification submitted by Becton, Dickinson and Company for the device "BD BBL™ Sensi-Disc™ Lefamulin 20µg (LMU-20)". The FDA issued a decision of Substantially Equivalent on June 7, 2023. The device falls under product code JTN (Susceptibility Test Discs, Antimicrobial), a Class II device regulated under 21 CFR 866.1620. Becton, Dickinson and Company has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
June 7, 2023
Date Received
March 9, 2023
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Susceptibility Test Discs, Antimicrobial
Device Class
Class II
Regulation Number
866.1620
Review Panel
MI
Submission Type